A Harvard Professor Made $400 Million in Moderna’s Biotech IPO
Timothy Springer, a professor of medicine at Harvard Medical School, speaks during a seminar at the Institute for Protein Innovation, a nonprofit he founded, in Boston, Massachusetts, U.S. (Photographer: Scott Eisen/Bloomberg)

A Harvard Professor Made $400 Million in Moderna’s Biotech IPO

(Bloomberg) -- On the Sunday before Moderna Inc. launched one of the biggest initial public offerings in biotechnology history, one of its earliest investors was giving a lecture about rocks.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.